Agoracom Blog

AGORACOM Small Cap TV “Best Of The Best” – November 26, 2014

Posted by AGORACOM-JC at 6:21 PM on Wednesday, November 26th, 2014

AGORACOM Founder, George Tsiolis and Chief Market Commentator, Allan Barry Go Via Satellite to discuss and debate Allan’s Best picks this week. Companies Included on this week’s show are:


Allan and George have already put their viewers well ahead of the game by starting their weekly broadcasts on July 11, 2013 on the thesis that great small-cap companies were so oversold they could not be ignored. One look at the TSX Venture Index proves they hit the nail on the head … but that doesn’t come close to telling the whole story with most of their picks far outperforming an index bloated with zombie companies.

Find out which companies Allan and George like this week by watching the video below!

Want to catch up on previous shows?

Weekly “Best Of The Best” Summarizing The Best Picks From Our Daily Shows. Posted Every Friday Afternoon Watch Here



Garibaldi drill tests new high-grade area north of Silver Eagle discovery hole

Posted by AGORACOM-JC at 5:32 PM on Wednesday, November 26th, 2014

VANCOUVER, Nov. 26, 2014 – Garibaldi Resources Corp. (TSX.V: GGI) (the “Company” or “Garibaldi”) is pleased to report that high-grade silver mineralization has been confirmed through assays from channel sampling 150 meters north of Silver Eagle discovery hole SE-14-01 at the Rodadero North Project in central Sonora State, Mexico. This area will be drill-tested beginning later this week in an attempt to expand the Silver Eagle system in a northerly direction.

All drill holes completed to date at Silver Eagle, with the exception of SE-14-05, have been to the south of SE-14-01 where mineralization remains open and has been traced for an additional 3 km south beyond the Reales target in sampling of surface outcrops and small underground workings. The Company eagerly anticipates receiving the next batch of assay results (drill holes SE-14-07 through SE-14-12) during the first half of December.

Silver Eagle is the westernmost of 11 target areas defined over more than 45 sq. km at Rodadero North where mineralization transitions from primarily high-grade silver at Silver Eagle, discovered through sampling and shallow drilling, to high-grade gold, silver and base metals trending eastward. A drill plan map for the Tarichi target, 2.5 km southeast of Silver Eagle, is now available at

Channel Samples Return Up To 881 g/t Ag

Two immediate drill holes will test for continuity of mineralization to depths of less than 100 meters at the new surface discovery north of SE-14-01. All five channel samples from a shallow pit returned significant silver grades – 881 g/t (28.3 oz/tonne), 771 g/t, 763 g/t, 452 g/t and 87 g/t. Widths ranged from 1.4 to 1.9 meters. The average grade was 604 g/t Ag over an average width of 1.6 meters.

Steve Regoci, President and CEO of Garibaldi, commented: “Given results generated to date by drilling, sampling and our hyperspectral technology, and the fact that this project is situated in the heart of a prolific mining region, we’re extremely excited with what we see at Rodadero as the emergence of a new mineral camp in central Sonora State.”

By the nature of the biases of sampling, the above results are not necessarily representative of mineralization at Rodadero North in general or, specifically, within the zones, structures or geological features that were sampled.

Mineralization at Silver Eagle is hosted in silicified conglomerate and overlying andesitic volcanic rocks along a north-northwest trending structural zone. Mineralization also appears to be associated with the stratigraphy of the conglomerate.

Rodadero North Video

To view a 2-minute Garibaldi video on the Rodadero discovery, please visit the homepage of or the following URL:

Quality Assurance & Control

Garibaldi maintains strict QA-QC protocols for all aspects of its exploration programs that include the systematic insertion of blanks and standards into each sample batch. Acme Labs (now part of the Bureau Veritis group that includes BSI Inspectorate) has performed assay analyses on Rodadero North drill core and some of the rock samples, while ALS Global (formerly ALS Chemex) has also performed some analyses on rock samples. All samples reported in this release were assayed using certified and industry standard assay techniques for gold, and multi-element packages for other elements and for over-limits. Au was analyzed by 30 or 50 gram fire assay with an atomic absorption finish, and other elements were analyzed by multi-element ICP.

Qualified Person

Dr. Craig Gibson, Certified Professional Geologist and a director of Garibaldi, is a non-arms-length Qualified Person for the Company’s Mexico projects and the direct manager of the technical programs operated under contract by Prospeccion Y Desorrollo Minera del Norte (ProDeMin). Dr. Gibson has reviewed this news release and approved the content thereof.

About Garibaldi

Garibaldi Resources Corp. is an active Canadian-based junior exploration company focused on creating shareholder value through discoveries and strategic development of its assets in some of the most prolific mining regions in Mexico and British Columbia

We seek safe harbor.


Per: “Steve Regoci”

Steve Regoci, President

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or the accuracy of this release.

SOURCE Garibaldi Resources Corp.

GARIBALDI RESOURCES CORP., 1150 – 409 Granville Street, Vancouver, BC V6C 1T2, Telephone: (604) 488-8851, Web site:

Uragold Acquires Silica Claims Directly Adjacent To Sitec Silicium Quebec Quartz

Posted by AGORACOM-JC at 10:25 AM on Wednesday, November 26th, 2014

Montreal, Quebec, / November 26 / Uragold Bay Resources Inc. (“Uragold”) (TSX Venture: UBR) is pleased to announce it has acquired, through map staking, two (2) silica claims directly adjacent to Sitec Silicium Quebec quartz mine located in the Charlevoix region of Quebec. Sitec Silicium Quebec quartz mine supplies silica for Sitec silicon metal foundry in Becancour and for the Elkem Metal Canada ferrosilicium foundry in Chicoutimi Quebec.

Quebec Quartz, Uragold’s wholly owned subsidiary, intends to explore the claims for quartzite extensions to the north of the Silicium Quebec Mine. The Galette sector of the Charlevoix region is knows to hold high purity quartzites. The regional geology is comprised of a paragenesis and pink garnetiferous granite with units of discernable quartzites within the paragenesis.

Patrick Levasseur, President and COO of Uragold stated, “This is an other great addition to our significant portfolio of high quality silica properties. Mr. Levasseur then added, “We continue to develop Quebec Quartz’s exciting high purity silica projects while developing two gold mines in the Beauce region of Quebec.”

About Silica

Quartz (SIO2) is one of the most abundant minerals. It occurs in many different settings throughout the geological record. High Purity Quartz deposits with low impurities are rare. However, only very few deposits are suitable in volume, quality and amenability to tailored refining methods for specialty high purity applications.

High Purity Silica (HPS) and Silicon Metal which is used in large part in the aluminum industry has become one of today’s key strategic minerals with applications in high-tech industries that include semiconductors, LCD displays, fused quartz tubing, microelectronics, solar silicon applications and recently, Silicon Anode Lithium Batteries.

“Frac Sand”, is a durable, high-purity quartz sand used to help produce petroleum fluids and prop up man-made fractures in shale rock formations through which oil and gas flows, demand is exploding.

The need for “Frac sand” is turning this segment into the top driver of value in the shale revolution, and this is having a major impact across all High Purity Quartz markets, as material once used to meet the needs of high-tech industries is being diverted to this market to meet product shortage.

“One of the major players in Eagle Ford is saying they’re short 6 million tons of 100 mesh for “Frac sand” alone in 2014 and they don’t know where to get it. And that’s just one player,” Rasool Mohammad, President and CEO of Select Sands Corporation told

About Quebec Quartz

Uragold 100 % wholly owned subsidiary, Quebec Quartz, by virtue of being a first mover into this market, succeeded in becoming the largest holder of distinct High Purity Quartz properties in Quebec. Quebec Quartz strategic portfolio of high purity silica (+99.5% SiO2) deposits and closed silicon metal mines in Quebec represent a unique and valuable asset. While different Parties interested in our properties have approached the Corporation, we are waiting until we receive previously announced labs results before advancing these discussions.

About Uragold Bay Resources Inc.

Uragold Bay Resources is a TSX-V listed Gold and High Purity Quartz exploration junior focused on generating free cash flow from mining operations. Our business model is centered on developing mining projects suited for smaller-scale start-up, (Capex < C$10M), that will generate high yield returns (IRR > 50%). Uragold will reach these goals by developing Quebec’s first placer mine in 50 years, the Beauce Placer Project developing and, in partnership with Golden Hope Mines, the Bellechasse-Timmins Gold Deposit.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information contact

Bernard J. Tourillon, Chairman and CEO
Patrick Levasseur, President and COO

Tel: (514) 846-3271

INTERVIEW: Supreme (SL:CSE) Discusses Construction Progress at 342,000 SQF. Medical Marijuana Production Facility

Posted by AGORACOM-JC at 8:22 PM on Tuesday, November 25th, 2014

Supreme Discusses Progress of 342K sqf. Medical Marijuana Production Facility


  • Significant progress made at its 342,000 square foot greenhouse facility located in Kincardine, Ontario
  • Moving quickly to implement its proposed plan to produce up to 24,000,000 grams of medical marijuana
  • Recently completed $1.7M financing
  • Received conditional pre-approval letter from Health Canada

Supreme is a Canadian-owned and operated company whose mission is to enhance the quality of life for their patients and clients by producing sun-grown medical marijuana of the highest standards, quality and value. The company’s vision is a client-centered, environmentally-friendly and affordable medical marijuana marketplace sustained by the marriage of commercial agriculture and traditional growing.

Hub On AGORACOM / Corporate Profile / Watch Interview!

Lexaria Develops Proprietary Cannabidiol Technology

Posted by AGORACOM-JC at 10:10 AM on Monday, November 24th, 2014

VANCOUVER, British Columbia, Nov. 24, 2014 (GLOBE NEWSWIRE) — A new study from Orrin Devinsky, MD, of the New York University School of Medicine, suggests that Cannabidiol (CBD) may radically reduce seizures in patients with epilepsy.

Dr. Devinsky administered cannabidiol to 23 patients with treatment-resistant epilepsy. Thirty-nine percent of the patients saw their seizure rates drop by more than 50%. Four patients (17%) had no seizures for the last month of treatment.

Lexaria (CSE:LXX) (OTCQB:LXRP) has acquired 51% of PoViva Corp, an innovative health company developing Cannabidiol (CBD)-infused products. Lexaria may increase its ownership position to 75% at a later date.

“Most CBD’s taste awful,” stated Lexaria CEO and Chairman Chris Bunka in an exclusive interview with Financial Press. “Marian Washington and Michelle Reillo – the two principals at PoViva – have developed patent-pending technology to bind CBD to a lipid. As well as enabling the body to process the CBDs more efficiently, this technology makes it taste much better.”

The first PoViva Tea by Lexaria will be a traditional black tea, which accounts for about 85% of all the tea consumed. Initially Lexaria will sell the CBD lipid-bound tea loosely – and then as the product line gets traction Bunka anticipates introducing flavored teas and tea bags.

In March, 2014 Lexaria entered into the medical marijuana market in Canada where it is legal federally. Its production license application is being reviewed by Health Canada.

“We continue to press for that license,” stated Bunka. “But we made an executive and board decision to build immediate value for the company pursuing opportunities in the hemp-based Cannabidiol (CBD) market – which does not require new licensing, laws or legislation.”

The Alternative Health sector is growing fast. A six year survey with 29,370 subjects monitored the adoption of “complementary and alternative medicine care professionals,” including “homeopathic, naturopathic, or herbalists.”

The study suggests that between 16.9 million and 18.5 million Americans are seeking an alternative health care professional at any given time.

“The US Department of Health has patented CBDs and claimed that they are beneficial in treating Parkinson’s, Alzheimer’s, Cancer, Cardio-vascular diseases and concussion,” stated Bunka. “An overwhelming body of research indicates that Cannabidiol has significant medicinal properties.”

Bunka sees Cannabidiol products as much more than a niche health market. There are many patients with Alzheimer’s and other diseases who don’t want to use marijuana.

Lexaria is planning to market its products to the 150 million daily tea drinkers in the United States. The market for CBDs is much larger than that of marijuana-users.

“We’re not changing focus, we’re sharpening it,” stated Bunka. “We are still in the same sector, but in a 100% legal part of it, which means we can produce foods that contain CBD and create short term cash flows for the company.”

Lexaria is in the process of launching a new e-commerce website and setting up a national distribution center, with 1-800 call ordering.

“Our marketing will include traditional media, direct marketing, and we also are building relationships with alternative health media outlets,” stated Bunka. “Some of these organizations have expressed interest in affiliate marketing campaigns so we are also exploring that.”

Bunka has a conservative approach to alternative medicine, including cannabis. The company has initiated a Responsible Marijuana Policy which states that Lexaria will not sell medical marijuana containing more than 0.3% THC to any medical marijuana patient under the age of 25.

Subsequent to Lexaria’s announcement, the College of Family Physicians of Canada created new guidelines that included the recommendation that medical marijuana in most cases would not be appropriate for patients under the age of 25.

Lexaria is currently investigating several popular food and drink sectors where its patent-pending lipid-binding Cannabidiol delivery system might prove effective. Lexaria has acquired a 3-year exclusive right to the patent-pending process to infuse CBD’s into all global markets outside of the USA.

The 2015 combined hot beverage markets of coffee and tea together, globally, is expected to be $69 Billion according to a report by Basu Majumder A., Bera B. and Rajan A.

According to the US Department of Health and Human Services Patent number 6,630,507, Cannabidiol is particularly advantageous to use because it avoids toxicity that is encountered with psychoactive cannabinoids at high doses.”

Lexaria continues to pursue the Health Canada MMPR Licensed Producer status by way of its joint venture in Burlington Ontario with Enertopia Corp. Meanwhile Bunka is focussed on producing cash flows from new initiatives; including the CBD-sectors (like epilepsy treatment) derived from already-legal hemp.

According to the Center for Disease Control and Prevention, Epilepsy affects about 2 million people in the United States and accounts for $15.5 billion in direct costs and indirect costs.

Lexaria is currently trading at .09 with a market capitalisation of $3.1 million.

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to are provided. Thank you.

CONTACT: Lexaria Corp.
         950 - 1130 West Pender Street Vancouver BC V6E 4A4
         p. 604 602 1675 f. 604 685 1602
Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway:

INTERVIEW: QE2 Acquisition Corp. (QE: TSX-V) – Robust Growth Marks This Compelling Infrastructure Play

Posted by AGORACOM-JC at 9:51 AM on Monday, November 24th, 2014


Robust Growth Marks This Compelling Infrastructure Play

Welcome to CEO Interviews a production of AGORACOM in which we speak to small cap CEOs and Executives about their companies.  With us today is Brent Buhler, VP Finance of QE2 Acquisition Corp.

  • Alberta-founded firm that acquires and grows well-managed, profitable, asset-backed, Alberta-based businesses in the infrastructure and utility service sectors.
  • More than just lip service, QE2 reported revenues of ~ $2.3M for the quarter ended July 31
  • Growth strategy is a mergers and acquisitions program which leverages the synergies that can be achieved by vertical and horizontal integration.

Hub On AGORACOM / Corporate Profile / Watch Interview Now!

Cannabis (MMJ) Goes Mainstream

Posted by AGORACOM-JC at 4:46 PM on Friday, November 21st, 2014

Vancouver, BC / November 24, 2014 / 3,500 well-dressed investors and entrepreneurs converged last week in Las Vegas in what was the marijuana industry’s biggest event to date by far – the 3rd annual Marijuana Business Conference and Expo.

It was a monumental event, bringing together some of the top agricultural companies in the country with experts in security, logistics, software, packaging, even Wall St. was there as well as several reported celebrity sightings. To say we have a very hot new sector in this country is an understatement.

Supreme Pharmaceuticals (SL-CSE) (SPRWF-OTC) is looking like a champion on this frontier, having built a high-tech pharmaceutical-grade greenhouse in Canada, ideally suited for cannabis cultivation on a large-scale.

“In May 2014 we purchased a 342,000 square foot agricultural greenhouse in Kincardine, Ontario,” stated Supremes’ Director of Operations in an exclusive interview with Financial Press, “since then we’ve deployed over $4 million dollars to convert it into a medical marijuana growing facility that exceeds the federal regulatory requirements.”

The speedy execution of the construction phase reflects the financial, entrepreneurial and operational mix of Supremes’ management team. The company has a solid track record in capital markets, logistics and the marijuana space.

In January, 2014 Supreme received a “Ready-to-Build” letter from the federal regulator indicating its proposal to produce up to 24,000 KG of medical marijuana per year met the regulatory requirements. The ready to build letter states that a producer’s license will be issued following a successful pre-licence inspection.

As the pre-license construction phase comes to a close, the company is now one step away from a green light to commercially produce medical marijuana. “Within the next few weeks we anticipate completing all of the pre-installed regulatory requirements” stated Fowler, “that means the security infrastructure, quality assurance and record keeping protocols are all in place – and we’re ready to put seeds in the ground and turn the lights on.”

Fowler describes the Kincardine greenhouse as the ideal facility to produce high quality, low cost medical marijuana, which will become one of Supremes’ cornerstone competitive advantages. In addition to the traditional cost-saving benefits of greenhouse agriculture, this greenhouse is uniquely suited to medical marijuana production. “The greenhouse is designed to be much shorter than a traditional agricultural greenhouse,” Fowler continued, “which is ideal for shorter plants like marijuana. This design means there are millions of cubic feet of air that we do not have to manage with our climate control systems. Reducing heating and cooling saves costs and boosts production efficiency.”

The size of the Kincardine facility gives Supreme a significant competitive advantage over other applicants. Health Canada’s regulatory guidance states that it intends to transform a sprawling cottage industry to a small number of scaled growing facilities. “Economies-of-scale have enabled us to make significant capital expenses with construction and quality control” said Fowler, “we’re doing premium installations that would not be practical for a 40,000 square foot facility.”

Supreme is also one of the first medical marijuana companies to take an agricultural approach to the production of medical marijuana. “This is an agricultural business first, which is why we are utilizing an agricultural facility and the latest technology for automated greenhouse agriculture” stated Fowler, “we have a large, secured, highly automated facility capable of providing a sustainable supply of a standardized medical product, something the medical community has told us is essential. One of the problems with smaller facilities is that they can run out of product, depending on the harvesting cycle. That can be a problem for patients who are only responsive to one strain. Supremes’ scale means that we can guarantee reliability and consistency in the supply chain.”

Fowler describes the biggest advantage Supreme gains from the greenhouse is the town of Kincardine itself. “The unforeseen benefit of this greenhouse facility in Kincardine had been the town itself,” stated Fowler, “We’ve got support from all levels of government, the local business community and the residents. Last Saturday we had a job fair, which was attended by over 600 locals, even though we only advertised twenty positions. That level of support is unprecedented in an industry where simply being left alone is a victory.”


Fowler has been involved in the medical marijuana industry for over a decade. He’s likely the only businessman and corporate lawyer in Canada who also has extensive hands-on experience with the medical marijuana patient community and marketplace.

Fowler also intends to use his experience as a patient advocate to help Supreme attract patients who require medical marijuana to treat various ailments. “We are going to institute innovating pricing models,” stated Fowler, “designed to accommodate patients on a limited budget and mitigate the fact insurance providers do not yet cover medical marijuana.”

On November 17, 2014 Supreme closed a non-brokered private placement financing which, based on investor interest, was increased in size twice, generating $1.78 million in additional capital for the Company.

Supreme Pharmaceuticals is currently trading on the Canadian Securities Exchange at $.41 with a market cap of $31 million.

Financial Press Legal Disclaimer/Disclosure to go at end of each client article:

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to are provided. Thank you.

Contact Information

Investor Relations
430-580 Hornby Street, Vancouver BC
V6C 3B6 Phone: (604) 674-2191

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway:

Frank C. Smeenk, President and CEO of KWG Resources to be Featured on CTV Power Play This Evening

Posted by AGORACOM-JC at 2:46 PM on Friday, November 21st, 2014

TORONTO, ONTARIO–(Nov. 21, 2014) - KWG Resources Inc. (“KWG” or the “Corporation“) (TSX VENTURE:KWG)(FRANKFURT:KW6) is pleased to announce that Frank C. Smeenk, President and CEO of KWG Resources will be featured on CTV Power Play this evening between the hours of 5 and 6pm ET.

Don Martin hosts CTV News Channel’s daily marquee political program, POWER PLAY from Monday to Friday at 5 p.m. and 8 p.m. ET.

With a fresh look at politics, politicians and plays for power, this is the political show of record for Canadians. Martin cuts through the rhetoric and highlights the people and players that dominate the political scene in Canada. Online at, viewers can catch episodes they’ve missed on the CTV Video Player.

Shares issued and outstanding: 777,842,468

KWG Resources Inc.
Bruce Hodgman


Enertopia Provides Footage of Planned MMPR Facility

Posted by AGORACOM-JC at 9:59 AM on Thursday, November 20th, 2014

Whitefish, MT / November 20, 2014 / Thus far there has only been a handful of companies approved by Health Canada for the MMPR program, including Tweed Inc. (TSX-V: TWD) and Organigram Inc. (TSX-V: OGI), while a number of other companies, such as Abattis Bioceuticals (OTC: ATTBF) continue to await their approvals from Health Canada.

While many publicly traded companies have been talking up their plans of becoming licensed producers, few have been very open about showing off their actual facilities and demonstrating how operations will work. Outdoor images of large warehouses and pictures of land from a mile high provide investors with very little information about what’s actually happening in these companies.

Enertopia Corp. (OTC: ENRT) recently released a four part video series in conjunction with its joint venture with The Green Canvas Ltd. After signing a joint venture agreement in February of 2014, the company has begun building and outfitting a 30,000 square foot facility – scalable to 55,000 square feet – to become compliant with Health Canada’s MMPR standards.

The video tour of the planned facility includes everything from the initial clone rooms, perimeter security, vegetative grow areas, vaults, multiple staging areas for flowering, and the lights that will be used for production.

In the overall 4 part video series, Enertopia’s management team discusses its operational plans within Canada’s rapidly growing medical marijuana industry, while also interviewing current medical marijuana patients that have been treated with the utmost compassion by Green Canvas. The Green Canvas’ history as a licensed producer under the legacy Medical Marijuana Access Regulations (“MMAR”) program also provides them with the ability to show actual current growing operations.

It is the expertise of these current operations that deserves special notice. On November 8th, 2014 the invite only Karma Cup was held to determine the best flowering varieties of marijuana for the indica, sativa, and hybrid entrants. With more than 70 entrants, the Green Canvas was awarded first place in the sativa category for their Ambrosia strain. This year the Green Canvas was also awarded first place in the Sativa category at the Prairie Medicinal Harvest Cup for the 4th year in a row, achievements that the company is very proud of since the sativa strains typically take much longer to grow, and are often times more effective at treating the medical conditions of their patients.

As well, in September the Green Canvas joint venture announced that it submitted its application to become a licensed producer, and that they are in correspondence with Health Canada regarding specific quality assurance reports. Facility upgrades are ongoing and the construction progress can be seen in the aforementioned videos, highlighting just how close the company is to bringing the planned facility to fruition.

Tim Selenski is the head grower for the Green Canvas Ltd. grow team, and has worked with the Canadian government via their MMAR program for over 10 year time. Since its involvement in the MMAR program, Green Canvas has been widely covered in the Canadian media and has become a trusted source for medical marijuana patients.

Click For More Information:

– Company Website –

– CannabisFN Profile Page –

Legal Disclaimer:

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit:

Enertopia and Lexaria Launch Medical Advisory Board

Posted by AGORACOM-JC at 8:04 AM on Thursday, November 20th, 2014

Vancouver, BC / November 20 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce that it and joint venture partner Lexaria Corp (LXRP) have launched a formal Medical Advisory Board to educate and advocate on behalf of all those who have medical needs that may be able to be met through the understanding and use of medical marijuana or through the use of cannabidiol (CBD) extracted from Industrial Hemp.

The Medical Advisory Board members specialize in various medical categories, and will work with health care professionals, patients, and prescribers of medical marijuana to promote greater understanding of medical marijuana and of CBD-enhanced products. There are believed by many to be a wide variety of medical conditions that might be affected in a positive way either by medical marijuana or by CBD’s, but in many cases the accuracy of claims may not be well understood at this time.

In particular, the use of high-cannabidiol strains that have little or no psychoactive effects on the patient, are of interest for use to treat many medical symptoms, according to existing studies and literature.

Recreational use of Marijuana is illegal in Canada, and illegal at the federal level in the United States because of the THC content; and this status has prevented and or greatly reduced the opportunity for peer-reviewed scientific study. Still, there is growing evidence that there could be real medical benefits somehow associated with either medical marijuana and/or the CBD’s within it. Despite the hurdles to conducting past research, there are 1,277 references today to Cannabidiol at research papers located at the US National Library of Medicine, National Institutes of Health website (

Many organizations are calling for additional research regarding medical marijuana. For instance the Arthritis Society in September announced it wants more research to study the impact of medical marijuana on pain, and that it is preparing to fund clinical studies. Jason McDougall, chair of the Arthritis Society’s scientific advisory committee and a pain researcher at Dalhousie University was quoted at that time saying, “I think it’s high time that we found something to help the 4.6-million Canadians living with arthritis and trying to do something to help”.

Enertopia hopes to announce its first meetings and/or conferences as soon as possible in this sector and the wellness sector in general as the company moves forward.

Robert McAllister, Enertopia Corporation., President & CEO said, “We are all witnessing today the emergence of grass roots movement where the patient finally comes first in all aspects of wellness.”

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit or call

Clark Kent, Media Inquiries: (647) 519-2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning the Advisory Medical Board. and any wellness opportunities and any positive impact on the Company, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The reader should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: